Re: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)848-849
    Number of pages2
    JournalJournal of Urology
    Volume193
    Issue number3
    DOIs
    StatePublished - Mar 1 2015

    ASJC Scopus subject areas

    • Urology

    Cite this